TG Therapeutics reported $10.76 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
Bayer EUR 5.93 0.68 Sep/2025
Biogen USD 14.02 4.63 Dec/2025
Corcept Therapeutics USD 41.9 52.28 Dec/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Novavax 2.28 346.03 Mar/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
TG Therapeutics USD 10.76 2.32 Dec/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025